BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Martinez N, Kornfeld H. Diabetes and immunity to tuberculosis. Eur J Immunol. 2014;44:617-626. [PMID: 24448841 DOI: 10.1002/eji.201344301] [Cited by in Crossref: 104] [Cited by in F6Publishing: 102] [Article Influence: 13.0] [Reference Citation Analysis]
Number Citing Articles
1 Huang LK, Wang HH, Lai YC, Chang SC. The impact of glycemic status on radiological manifestations of pulmonary tuberculosis in diabetic patients. PLoS One 2017;12:e0179750. [PMID: 28628646 DOI: 10.1371/journal.pone.0179750] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
2 Sinha P, Moll AP, Brooks RP, Deng YH, Shenoi SV. Synergism between diabetes and human immunodeficiency virus in increasing the risk of tuberculosis. Int J Tuberc Lung Dis 2018;22:793-9. [PMID: 29914606 DOI: 10.5588/ijtld.17.0936] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
3 Mahon RN, Hafner R. Immune Cell Regulatory Pathways Unexplored as Host-Directed Therapeutic Targets for Mycobacterium tuberculosis: An Opportunity to Apply Precision Medicine Innovations to Infectious Diseases. Clin Infect Dis 2015;61Suppl 3:S200-16. [PMID: 26409283 DOI: 10.1093/cid/civ621] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 4.2] [Reference Citation Analysis]
4 Jenjaroen K, Chumseng S, Sumonwiriya M, Ariyaprasert P, Chantratita N, Sunyakumthorn P, Hongsuwan M, Wuthiekanun V, Fletcher HA, Teparrukkul P, Limmathurotsakul D, Day NP, Dunachie SJ. T-Cell Responses Are Associated with Survival in Acute Melioidosis Patients. PLoS Negl Trop Dis 2015;9:e0004152. [PMID: 26495852 DOI: 10.1371/journal.pntd.0004152] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 5.9] [Reference Citation Analysis]
5 Barron MM, Shaw KM, Bullard KM, Ali MK, Magee MJ. Diabetes is associated with increased prevalence of latent tuberculosis infection: Findings from the National Health and Nutrition Examination Survey, 2011-2012. Diabetes Res Clin Pract 2018;139:366-79. [PMID: 29574108 DOI: 10.1016/j.diabres.2018.03.022] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 4.5] [Reference Citation Analysis]
6 Hensel RL, Kempker RR, Tapia J, Oladele A, Blumberg HM, Magee MJ. Increased risk of latent tuberculous infection among persons with pre-diabetes and diabetes mellitus. Int J Tuberc Lung Dis 2016;20:71-8. [PMID: 26688531 DOI: 10.5588/ijtld.15.0457] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 4.3] [Reference Citation Analysis]
7 Medellín-Garibay SE, Cortez-Espinosa N, Milán-Segovia RC, Magaña-Aquino M, Vargas-Morales JM, González-Amaro R, Portales-Pérez DP, Romano-Moreno S. Clinical Pharmacokinetics of Rifampin in Patients with Tuberculosis and Type 2 Diabetes Mellitus: Association with Biochemical and Immunological Parameters. Antimicrob Agents Chemother 2015;59:7707-14. [PMID: 26438503 DOI: 10.1128/AAC.01067-15] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
8 Chiang CY, Bai KJ, Lin HH, Chien ST, Lee JJ, Enarson DA, Lee TI, Yu MC. The influence of diabetes, glycemic control, and diabetes-related comorbidities on pulmonary tuberculosis. PLoS One 2015;10:e0121698. [PMID: 25822974 DOI: 10.1371/journal.pone.0121698] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 6.9] [Reference Citation Analysis]
9 Htun NS, Odermatt P, Eze IC, Boillat-Blanco N, D'Acremont V, Probst-Hensch N. Is diabetes a risk factor for a severe clinical presentation of dengue? PLoS Negl Trop Dis. 2015;9:e0003741. [PMID: 25909658 DOI: 10.1371/journal.pntd.0003741] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 5.3] [Reference Citation Analysis]
10 Blanco-Guillot F, Delgado-Sánchez G, Mongua-Rodríguez N, Cruz-Hervert P, Ferreyra-Reyes L, Ferreira-Guerrero E, Yanes-Lane M, Montero-Campos R, Bobadilla-Del-Valle M, Torres-González P, Ponce-de-León A, Sifuentes-Osornio J, Garcia-Garcia L. Molecular clustering of patients with diabetes and pulmonary tuberculosis: A systematic review and meta-analysis. PLoS One 2017;12:e0184675. [PMID: 28902922 DOI: 10.1371/journal.pone.0184675] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
11 Daryabor G, Atashzar MR, Kabelitz D, Meri S, Kalantar K. The Effects of Type 2 Diabetes Mellitus on Organ Metabolism and the Immune System. Front Immunol 2020;11:1582. [PMID: 32793223 DOI: 10.3389/fimmu.2020.01582] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 10.0] [Reference Citation Analysis]
12 Kumar NP, Banurekha VV, Nair D, Sridhar R, Kornfeld H, Nutman TB, Babu S. Coincident pre-diabetes is associated with dysregulated cytokine responses in pulmonary tuberculosis. PLoS One 2014;9:e112108. [PMID: 25393696 DOI: 10.1371/journal.pone.0112108] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.8] [Reference Citation Analysis]
13 Kumar NP, Moideen K, Viswanathan V, Shruthi BS, Sivakumar S, Menon PA, Kornfeld H, Babu S. Elevated levels of matrix metalloproteinases reflect severity and extent of disease in tuberculosis-diabetes co-morbidity and are predominantly reversed following standard anti-tuberculosis or metformin treatment. BMC Infect Dis 2018;18:345. [PMID: 30045688 DOI: 10.1186/s12879-018-3246-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
14 Tasaka M, Koeda E, Takahashi C, Ota M. A tuberculosis outbreak in a psychiatric hospital: Kanagawa, Japan, 2012. Epidemiol Infect 2020;148:e7. [PMID: 31933448 DOI: 10.1017/S0950268819002206] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
15 Cheekatla SS, Tripathi D, Venkatasubramanian S, Nathella PK, Paidipally P, Ishibashi M, Welch E, Tvinnereim AR, Ikebe M, Valluri VL, Babu S, Kornfeld H, Vankayalapati R. NK-CD11c+ Cell Crosstalk in Diabetes Enhances IL-6-Mediated Inflammation during Mycobacterium tuberculosis Infection. PLoS Pathog 2016;12:e1005972. [PMID: 27783671 DOI: 10.1371/journal.ppat.1005972] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
16 Henao-Tamayo M, Shanley CA, Verma D, Zilavy A, Stapleton MC, Furney SK, Podell B, Orme IM. The Efficacy of the BCG Vaccine against Newly Emerging Clinical Strains of Mycobacterium tuberculosis. PLoS One 2015;10:e0136500. [PMID: 26368806 DOI: 10.1371/journal.pone.0136500] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 3.9] [Reference Citation Analysis]
17 Restrepo BI. Diabetes and Tuberculosis. Microbiol Spectr 2016;4. [PMID: 28084206 DOI: 10.1128/microbiolspec.TNMI7-0023-2016] [Cited by in Crossref: 35] [Cited by in F6Publishing: 23] [Article Influence: 7.0] [Reference Citation Analysis]
18 Kumar NP, George PJ, Kumaran P, Dolla CK, Nutman TB, Babu S. Diminished systemic and antigen-specific type 1, type 17, and other proinflammatory cytokines in diabetic and prediabetic individuals with latent Mycobacterium tuberculosis infection. J Infect Dis 2014;210:1670-8. [PMID: 24907382 DOI: 10.1093/infdis/jiu329] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 3.6] [Reference Citation Analysis]
19 Kewcharoenwong C, Saenwongsa W, Willcocks SJ, Bancroft GJ, Fletcher HA, Lertmemongkolchai G. Glibenclamide alters interleukin-8 and interleukin-1β of primary human monocytes from diabetes patients against Mycobacterium tuberculosis infection. Tuberculosis (Edinb) 2020;123:101939. [PMID: 32452426 DOI: 10.1016/j.tube.2020.101939] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Queiroz-Telles F, Buccheri R, Benard G. Sporotrichosis In Immunocompromised Hosts. J Fungi (Basel) 2019;5:E8. [PMID: 30641918 DOI: 10.3390/jof5010008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 4.7] [Reference Citation Analysis]
21 Mave V, Gaikwad S, Barthwal M, Chandanwale A, Lokhande R, Kadam D, Dharmshale S, Bharadwaj R, Kagal A, Pradhan N, Deshmukh S, Atre S, Sahasrabudhe T, Meshram S, Kakrani A, Kulkarni V, Raskar S, Suryavanshi N, Kornfeld H, Dooley KE, Chon S, Gupte A, Gupta A, Gupte N, Golub JE. Diabetes Mellitus and Tuberculosis Treatment Outcomes in Pune, India. Open Forum Infect Dis 2021;8:ofab097. [PMID: 33884278 DOI: 10.1093/ofid/ofab097] [Reference Citation Analysis]
22 Morris JL, Bridson TL, Alim MA, Rush CM, Rudd DM, Govan BL, Ketheesan N. Development of a diet-induced murine model of diabetes featuring cardinal metabolic and pathophysiological abnormalities of type 2 diabetes. Biol Open 2016;5:1149-62. [PMID: 27402965 DOI: 10.1242/bio.016790] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
23 Martinez N, Ketheesan N, West K, Vallerskog T, Kornfeld H. Impaired Recognition of Mycobacterium tuberculosis by Alveolar Macrophages From Diabetic Mice. J Infect Dis 2016;214:1629-37. [PMID: 27630197 DOI: 10.1093/infdis/jiw436] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 5.7] [Reference Citation Analysis]
24 Ronacher K, Joosten SA, van Crevel R, Dockrell HM, Walzl G, Ottenhoff TH. Acquired immunodeficiencies and tuberculosis: focus on HIV/AIDS and diabetes mellitus. Immunol Rev 2015;264:121-37. [PMID: 25703556 DOI: 10.1111/imr.12257] [Cited by in Crossref: 59] [Cited by in F6Publishing: 50] [Article Influence: 8.4] [Reference Citation Analysis]
25 Wachinou AP, Ade S, Ndour Mbaye M, Bah B, Baldé N, Gninkoun J, Bekou W, Sarr M, Bah Sow O, Affolabi D, Merle C. Tuberculosis prevalence and associated factors among persons with diabetes mellitus after intensified case finding in three West African countries. Multidiscip Respir Med 2021;16:783. [PMID: 34557300 DOI: 10.4081/mrm.2021.783] [Reference Citation Analysis]
26 Kornfeld H, Sahukar SB, Procter-Gray E, Kumar NP, West K, Kane K, Natarajan M, Li W, Babu S, Viswanathan V. Impact of Diabetes and Low Body Mass Index on Tuberculosis Treatment Outcomes. Clin Infect Dis 2020;71:e392-8. [PMID: 31955202 DOI: 10.1093/cid/ciaa054] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
27 Boillat-Blanco N, Tumbo AN, Perreau M, Amelio P, Ramaiya KL, Mganga M, Schindler C, Gagneux S, Reither K, Probst-Hensch N, Pantaleo G, Daubenberger C, Portevin D. Hyperglycaemia is inversely correlated with live M. bovis BCG-specific CD4+ T cell responses in Tanzanian adults with latent or active tuberculosis. Immun Inflamm Dis 2018;6:345-53. [PMID: 29642283 DOI: 10.1002/iid3.222] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
28 Tsai IF, Kuo CP, Lin AB, Chien MN, Ho HT, Wei TY, Wu CL, Lu YT. Potential effect of ezetimibe against Mycobacterium tuberculosis infection in type II diabetes. Respirology 2017;22:559-66. [PMID: 27879023 DOI: 10.1111/resp.12948] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
29 Kumar NP, Fukutani KF, Shruthi BS, Alves T, Silveira-Mattos PS, Rocha MS, West K, Natarajan M, Viswanathan V, Babu S, Andrade BB, Kornfeld H. Persistent inflammation during anti-tuberculosis treatment with diabetes comorbidity. Elife 2019;8:e46477. [PMID: 31271354 DOI: 10.7554/eLife.46477] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
30 Kumar NP, Moideen K, Nancy A, Viswanathan V, Shruthi BS, Sivakumar S, Natarajan M, Kornfeld H, Babu S. Heterogeneity in the cytokine profile of tuberculosis - diabetes co-morbidity. Cytokine 2020;125:154824. [PMID: 31472402 DOI: 10.1016/j.cyto.2019.154824] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
31 Tripathi D, Radhakrishnan RK, Sivangala Thandi R, Paidipally P, Devalraju KP, Neela VSK, McAllister MK, Samten B, Valluri VL, Vankayalapati R. IL-22 produced by type 3 innate lymphoid cells (ILC3s) reduces the mortality of type 2 diabetes mellitus (T2DM) mice infected with Mycobacterium tuberculosis. PLoS Pathog 2019;15:e1008140. [PMID: 31809521 DOI: 10.1371/journal.ppat.1008140] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
32 Verma A, Radotra BD, Sharma S. Role of resuscitation promoting factors in reactivation of latent tuberculosis during high glucose conditions employing human granuloma in vitro model. Microb Pathog 2021;158:105068. [PMID: 34245822 DOI: 10.1016/j.micpath.2021.105068] [Reference Citation Analysis]
33 Pizzol D, Di Gennaro F, Chhaganlal KD, Fabrizio C, Monno L, Putoto G, Saracino A. Tuberculosis and diabetes: current state and future perspectives. Trop Med Int Health 2016;21:694-702. [PMID: 27102229 DOI: 10.1111/tmi.12704] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 5.5] [Reference Citation Analysis]
34 Kumar NP, Moideen K, Viswanathan V, Kornfeld H, Babu S. Effect of standard tuberculosis treatment on naive, memory and regulatory T-cell homeostasis in tuberculosis-diabetes co-morbidity. Immunology 2016;149:87-97. [PMID: 27289086 DOI: 10.1111/imm.12632] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
35 Boulanger RF, Hunt MR, Benatar SR. Where Caring Is Sharing: Evolving Ethical Considerations in Tuberculosis Prevention Among Healthcare Workers. Clin Infect Dis 2016;62 Suppl 3:S268-74. [PMID: 27118857 DOI: 10.1093/cid/ciw013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
36 Magee MJ, Trost SL, Salindri AD, Amere G, Day CL, Gandhi NR. Adults with Mycobacterium tuberculosis infection and pre-diabetes have increased levels of QuantiFERON interferon-gamma responses. Tuberculosis (Edinb) 2020;122:101935. [PMID: 32501260 DOI: 10.1016/j.tube.2020.101935] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
37 Alim MA, Kupz A, Sikder S, Rush C, Govan B, Ketheesan N. Increased susceptibility to Mycobacterium tuberculosis infection in a diet-induced murine model of type 2 diabetes. Microbes Infect 2020;22:303-11. [PMID: 32234542 DOI: 10.1016/j.micinf.2020.03.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
38 Hawn TR, Shah JA, Kalman D. New tricks for old dogs: countering antibiotic resistance in tuberculosis with host-directed therapeutics. Immunol Rev 2015;264:344-62. [PMID: 25703571 DOI: 10.1111/imr.12255] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 6.1] [Reference Citation Analysis]
39 Sheng YF, Qi Q. Association of chemotactic chemokine ligand 5 rs2107538 polymorphism with tuberculosis susceptibility: A meta-analysis. Innate Immun 2020;26:358-63. [PMID: 31874580 DOI: 10.1177/1753425919891662] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
40 Alexander M, Gupta A, Mathad JS. Is there a connection between gestational diabetes mellitus, human immunodeficiency virus infection, and tuberculosis? Int J Tuberc Lung Dis 2019;23:19-25. [PMID: 30674375 DOI: 10.5588/ijtld.18.0337] [Reference Citation Analysis]
41 Fernández RDV, Díaz A, Bongiovanni B, Gallucci G, Bértola D, Gardeñez W, Lioi S, Bertolin Y, Galliano R, Bay ML, Bottasso O, D'Attilio L. Evidence for a More Disrupted Immune-Endocrine Relation and Cortisol Immunologic Influences in the Context of Tuberculosis and Type 2 Diabetes Comorbidity. Front Endocrinol (Lausanne) 2020;11:126. [PMID: 32265833 DOI: 10.3389/fendo.2020.00126] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Bobhate A, Viswanathan V, Aravindhan V. Anti-inflammatory cytokines IL-27, IL-10, IL-1Ra and TGF-β in subjects with increasing grades of glucose intolerence (DM-LTB-2). Cytokine 2021;137:155333. [PMID: 33045524 DOI: 10.1016/j.cyto.2020.155333] [Reference Citation Analysis]
43 Masood KI, Irfan M, Masood Q, Yameen M, Jamil B, Ram N, Rao S, Rottenberg M, Hasan Z. Latent M. tuberculosis infection is associated with increased inflammatory cytokine and decreased suppressor of cytokine signalling (SOCS)‐3 in the diabetic host. Scand J Immunol. [DOI: 10.1111/sji.13134] [Reference Citation Analysis]
44 Restrepo BI, Schlesinger LS. Impact of diabetes on the natural history of tuberculosis. Diabetes Res Clin Pract 2014;106:191-9. [PMID: 25082309 DOI: 10.1016/j.diabres.2014.06.011] [Cited by in Crossref: 54] [Cited by in F6Publishing: 48] [Article Influence: 6.8] [Reference Citation Analysis]
45 Toniolo A, Cassani G, Puggioni A, Rossi A, Colombo A, Onodera T, Ferrannini E. The diabetes pandemic and associated infections: suggestions for clinical microbiology. Rev Med Microbiol 2019;30:1-17. [PMID: 30662163 DOI: 10.1097/MRM.0000000000000155] [Cited by in Crossref: 40] [Cited by in F6Publishing: 31] [Article Influence: 10.0] [Reference Citation Analysis]
46 Alfarisi O, Mave V, Gaikwad S, Sahasrabudhe T, Ramachandran G, Kumar H, Gupte N, Kulkarni V, Deshmukh S, Atre S, Raskar S, Lokhande R, Barthwal M, Kakrani A, Chon S, Gupta A, Golub JE, Dooley KE. Effect of Diabetes Mellitus on the Pharmacokinetics and Pharmacodynamics of Tuberculosis Treatment. Antimicrob Agents Chemother 2018;62:e01383-18. [PMID: 30126955 DOI: 10.1128/AAC.01383-18] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 2.8] [Reference Citation Analysis]
47 Wang H, Wang C, Wang L, Liu T, Wang Z, You H, Zheng Y, Luo D. Orai1 downregulation impairs lymphocyte function in type 2 diabetes mellitus. Biochem Biophys Res Commun 2018;500:384-90. [PMID: 29654766 DOI: 10.1016/j.bbrc.2018.04.083] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
48 Martinez N, Ketheesan N, Martens GW, West K, Lien E, Kornfeld H. Defects in early cell recruitment contribute to the increased susceptibility to respiratory Klebsiella pneumoniae infection in diabetic mice. Microbes Infect 2016;18:649-55. [PMID: 27256462 DOI: 10.1016/j.micinf.2016.05.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
49 Pan SW, Yen YF, Kou YR, Chuang PH, Su VY, Feng JY, Chan YJ, Su WJ. The Risk of TB in Patients With Type 2 Diabetes Initiating Metformin vs Sulfonylurea Treatment. Chest 2018;153:1347-57. [PMID: 29253553 DOI: 10.1016/j.chest.2017.11.040] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 5.2] [Reference Citation Analysis]
50 Evangelista MDSN, Maia R, Toledo JP, Abreu RGD, Barreira D. Tuberculosis associated with diabetes mellitus by age group in Brazil: a retrospective cohort study, 2007–2014. The Brazilian Journal of Infectious Diseases 2020;24:130-6. [DOI: 10.1016/j.bjid.2020.03.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
51 Kumar Nathella P, Babu S. Influence of diabetes mellitus on immunity to human tuberculosis. Immunology 2017;152:13-24. [PMID: 28543817 DOI: 10.1111/imm.12762] [Cited by in Crossref: 57] [Cited by in F6Publishing: 51] [Article Influence: 11.4] [Reference Citation Analysis]
52 Cuadros DF, Li J, Musuka G, Awad SF. Spatial epidemiology of diabetes: Methods and insights. World J Diabetes 2021; 12(7): 1042-1056 [PMID: 34326953 DOI: 10.4239/wjd.v12.i7.1042] [Reference Citation Analysis]
53 Bridson TL, Govan BL, Norton RE, Schofield L, Ketheesan N. The double burden: a new-age pandemic meets an ancient infection. Trans R Soc Trop Med Hyg 2014;108:676-8. [PMID: 25159218 DOI: 10.1093/trstmh/tru135] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
54 Martinez N, Vallerskog T, West K, Nunes-Alves C, Lee J, Martens GW, Behar SM, Kornfeld H. Chromatin decondensation and T cell hyperresponsiveness in diabetes-associated hyperglycemia. J Immunol 2014;193:4457-68. [PMID: 25246495 DOI: 10.4049/jimmunol.1401125] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
55 Yoo JE, Kim D, Han K, Rhee SY, Shin DW, Lee H. Diabetes Status and Association With Risk of Tuberculosis Among Korean Adults. JAMA Netw Open 2021;4:e2126099. [PMID: 34546370 DOI: 10.1001/jamanetworkopen.2021.26099] [Reference Citation Analysis]
56 Lang S, Sun J, Wang X, Xiao Y, Wang J, Zhang M, Ao T, Wang J. Asymptomatic pulmonary tuberculosis mimicking lung cancer on imaging: A retrospective study. Exp Ther Med 2017;14:2180-8. [PMID: 28962139 DOI: 10.3892/etm.2017.4737] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
57 Sheedy FJ, Divangahi M. Targeting immunometabolism in host defence against Mycobacterium tuberculosis. Immunology 2021;162:145-59. [PMID: 33020911 DOI: 10.1111/imm.13276] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
58 Leal ML, Maciel ELN, Cade NV. Factors associated with tuberculosis in a population of diabetics: A case-control study. Cien Saude Colet 2018;24:3247-56. [PMID: 31508745 DOI: 10.1590/1413-81232018249.30392017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
59 Lee PH, Fu H, Lai TC, Chiang CY, Chan CC, Lin HH. Glycemic Control and the Risk of Tuberculosis: A Cohort Study. PLoS Med 2016;13:e1002072. [PMID: 27505150 DOI: 10.1371/journal.pmed.1002072] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 7.0] [Reference Citation Analysis]
60 Kumar NP, Moideen K, Sivakumar S, Menon PA, Viswanathan V, Kornfeld H, Babu S. Tuberculosis-diabetes co-morbidity is characterized by heightened systemic levels of circulating angiogenic factors. J Infect 2017;74:10-21. [PMID: 27717783 DOI: 10.1016/j.jinf.2016.08.021] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
61 Ragouraman D, Priyadharsini RP, Venkatesh C. Prevalence of tuberculosis and diabetes comorbidity in patients attending secondary healthcare hospital in south India: A retrospective study. J Family Med Prim Care 2021;10:1241-5. [PMID: 34041158 DOI: 10.4103/jfmpc.jfmpc_1984_20] [Reference Citation Analysis]
62 Foe-Essomba JR, Kenmoe S, Tchatchouang S, Ebogo-Belobo JT, Mbaga DS, Kengne-Ndé C, Mahamat G, Kame-Ngasse GI, Noura EA, Mbongue Mikangue CA, Feudjio AF, Taya-Fokou JB, Touangnou-Chamda SA, Nayang-Mundo RA, Nyebe I, Magoudjou-Pekam JN, Yéngué JF, Djukouo LG, Demeni Emoh CP, Tazokong HR, Bowo-Ngandji A, Lontchi-Yimagou E, Kaiyven AL, Donkeng Donfack VF, Njouom R, Mbanya JC, Mbacham WF, Eyangoh S. Diabetes mellitus and tuberculosis, a systematic review and meta-analysis with sensitivity analysis for studies comparable for confounders. PLoS One 2021;16:e0261246. [PMID: 34890419 DOI: 10.1371/journal.pone.0261246] [Reference Citation Analysis]
63 Magee M, Ali M, Prabhakaran D, Ajay VS, Narayan KMV. Integrated Public Health and Health Service Delivery for Noncommunicable Diseases and Comorbid Infectious Diseases and Mental Health. In: Prabhakaran D, Anand S, Gaziano TA, Mbanya J, Wu Y, Nugent R, editors. Disease Control Priorities, Third Edition (Volume 5): Cardiovascular, Respiratory, and Related Disorders. The World Bank; 2017. pp. 287-303. [DOI: 10.1596/978-1-4648-0518-9_ch16] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
64 Workneh MH, Bjune GA, Yimer SA. Prevalence and Associated Factors of Diabetes Mellitus among Tuberculosis Patients in South-Eastern Amhara Region, Ethiopia: A Cross Sectional Study. PLoS One 2016;11:e0147621. [PMID: 26808967 DOI: 10.1371/journal.pone.0147621] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 4.2] [Reference Citation Analysis]
65 Mnyambwa NP, Philbert D, Kimaro G, Wandiga S, Kirenga B, Mmbaga BT, Muttamba W, Najjingo I, Walusimbi S, Nuwarinda R, Okelloh D, Semvua H, Ngocho J, Senkoro M, Stephen O, Castelnuovo B, Wilfred A, Mgina E, Sanga C, Aman F, Kahwa A, Mfinanga S, Ngadaya E. Gaps related to screening and diagnosis of tuberculosis in care cascade in selected health facilities in East Africa countries: A retrospective study. J Clin Tuberc Other Mycobact Dis 2021;25:100278. [PMID: 34622035 DOI: 10.1016/j.jctube.2021.100278] [Reference Citation Analysis]
66 Almeida-Junior JL, Gil-Santana L, Oliveira CA, Castro S, Cafezeiro AS, Daltro C, Netto EM, Kornfeld H, Andrade BB. Glucose Metabolism Disorder Is Associated with Pulmonary Tuberculosis in Individuals with Respiratory Symptoms from Brazil. PLoS One 2016;11:e0153590. [PMID: 27078026 DOI: 10.1371/journal.pone.0153590] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
67 Prada-Medina CA, Fukutani KF, Pavan Kumar N, Gil-Santana L, Babu S, Lichtenstein F, West K, Sivakumar S, Menon PA, Viswanathan V, Andrade BB, Nakaya HI, Kornfeld H. Systems Immunology of Diabetes-Tuberculosis Comorbidity Reveals Signatures of Disease Complications. Sci Rep 2017;7:1999. [PMID: 28515464 DOI: 10.1038/s41598-017-01767-4] [Cited by in Crossref: 57] [Cited by in F6Publishing: 52] [Article Influence: 11.4] [Reference Citation Analysis]
68 Kyaw NTT, Satyanarayana S, Oo HN, Kumar AMV, Harries AD, Aung ST, Kyaw KWY, Phyo KH, Aung TK, Magee MJ. Hyperglycemia and Risk of All-cause Mortality Among People Living With HIV With and Without Tuberculosis Disease in Myanmar (2011-2017). Open Forum Infect Dis 2019;6:ofy355. [PMID: 30697575 DOI: 10.1093/ofid/ofy355] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
69 Olive AJ, Sassetti CM. Metabolic crosstalk between host and pathogen: sensing, adapting and competing. Nat Rev Microbiol 2016;14:221-34. [PMID: 26949049 DOI: 10.1038/nrmicro.2016.12] [Cited by in Crossref: 101] [Cited by in F6Publishing: 86] [Article Influence: 16.8] [Reference Citation Analysis]
70 Cadena J, Rathinavelu S, Lopez-Alvarenga JC, Restrepo BI. The re-emerging association between tuberculosis and diabetes: Lessons from past centuries. Tuberculosis (Edinb) 2019;116S:S89-97. [PMID: 31085129 DOI: 10.1016/j.tube.2019.04.015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
71 Lewinsohn DM, Lewinsohn DA. New Concepts in Tuberculosis Host Defense. Clin Chest Med 2019;40:703-19. [PMID: 31731979 DOI: 10.1016/j.ccm.2019.07.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
72 Ahmad S, Mokaddas E, Al-Mutairi NM. Prevalence of tuberculosis and multidrug resistant tuberculosis in the Middle East Region. Expert Rev Anti Infect Ther 2018;16:709-21. [PMID: 30173588 DOI: 10.1080/14787210.2018.1519393] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
73 Olive AJ, Sassetti CM. New TB treatments hiding in plain sight. EMBO Mol Med 2015;7:125-6. [PMID: 25535253 DOI: 10.15252/emmm.201404815] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
74 Shen TC, Lin CL, Wei CC, Liao WC, Chen WC, Chen CH, Tu CY, Hsia TC, Shih CM, Hsu WH, Li CH, Sung FC. Increased risk of tuberculosis in patients with type 1 diabetes mellitus: results from a population-based cohort study in Taiwan. Medicine (Baltimore) 2014;93:e96. [PMID: 25310745 DOI: 10.1097/MD.0000000000000096] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 2.1] [Reference Citation Analysis]
75 Oehlers SH. Revisiting hypoxia therapies for tuberculosis. Clin Sci (Lond) 2019;133:1271-80. [PMID: 31209098 DOI: 10.1042/CS20190415] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
76 Alim MA, Sikder S, Bridson TL, Rush CM, Govan BL, Ketheesan N. Anti-mycobacterial function of macrophages is impaired in a diet induced model of type 2 diabetes. Tuberculosis (Edinb) 2017;102:47-54. [PMID: 28061952 DOI: 10.1016/j.tube.2016.12.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
77 Pan SW, Yen YF, Feng JY, Chuang PH, Su VY, Kou YR, Su WJ, Chan YJ. Opposite effects of statins on the risk of tuberculosis and herpes zoster in patients with diabetes: A population-based cohort study. Br J Clin Pharmacol 2020;86:569-79. [PMID: 31633826 DOI: 10.1111/bcp.14142] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
78 Kumar NP, Sridhar R, Nair D, Banurekha VV, Nutman TB, Babu S. Type 2 diabetes mellitus is associated with altered CD8(+) T and natural killer cell function in pulmonary tuberculosis. Immunology 2015;144:677-86. [PMID: 25363329 DOI: 10.1111/imm.12421] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 5.6] [Reference Citation Analysis]
79 Badawi A, Sayegh S, Sallam M, Sadoun E, Al-Thani M, Alam MW, Arora P. The global relationship between the prevalence of diabetes mellitus and incidence of tuberculosis: 2000-2012. Glob J Health Sci 2014;7:183-91. [PMID: 25716376 DOI: 10.5539/gjhs.v7n2p183] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
80 Martinez L, Zhu L, Castellanos ME, Liu Q, Chen C, Hallowell BD, Whalen CC. Glycemic Control and the Prevalence of Tuberculosis Infection: A Population-based Observational Study. Clin Infect Dis 2017;65:2060-8. [PMID: 29059298 DOI: 10.1093/cid/cix632] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
81 Bobadilla-Del-Valle M, Leal-Vega F, Torres-Gonzalez P, Ordaz-Vazquez A, Garcia-Garcia ML, Tovar-Vargas MLA, Delgado-Sanchez G, Guerra De Blas PDC, Wallis RS, Ponce-De-León A, Sifuentes-Osornio J. Mycobacterial Growth Inhibition Assay (MGIA) as a Host Directed Diagnostic Tool for the Evaluation of the Immune Response in Subjects Living With Type 2 Diabetes Mellitus. Front Cell Infect Microbiol 2021;11:640707. [PMID: 34084753 DOI: 10.3389/fcimb.2021.640707] [Reference Citation Analysis]
82 Ayelign B, Negash M, Genetu M, Wondmagegn T, Shibabaw T. Immunological Impacts of Diabetes on the Susceptibility of Mycobacterium tuberculosis. J Immunol Res 2019;2019:6196532. [PMID: 31583258 DOI: 10.1155/2019/6196532] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 9.7] [Reference Citation Analysis]
83 Kumar NP, Moideen K, Nancy A, Viswanathan V, Shruthi BS, Sivakumar S, Hissar S, Kornfeld H, Babu S. Systemic RAGE ligands are upregulated in tuberculosis individuals with diabetes co-morbidity and modulated by anti-tuberculosis treatment and metformin therapy. BMC Infect Dis. 2019;19:1039. [PMID: 31818258 DOI: 10.1186/s12879-019-4648-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
84 Li H, Li Y, Sun T, Du W, Li C, Suo C, Meng Y, Liang Q, Lan T, Zhong M, Yang S, Niu C, Li D, Ding C. Unveil the transcriptional landscape at the Cryptococcus-host axis in mice and nonhuman primates. PLoS Negl Trop Dis 2019;13:e0007566. [PMID: 31329596 DOI: 10.1371/journal.pntd.0007566] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
85 van Crevel R, van de Vijver S, Moore DAJ. The global diabetes epidemic: what does it mean for infectious diseases in tropical countries? Lancet Diabetes Endocrinol 2017;5:457-68. [PMID: 27499355 DOI: 10.1016/S2213-8587(16)30081-X] [Cited by in Crossref: 63] [Cited by in F6Publishing: 34] [Article Influence: 10.5] [Reference Citation Analysis]
86 Lee MR, Huang YP, Kuo YT, Luo CH, Shih YJ, Shu CC, Wang JY, Ko JC, Yu CJ, Lin HH. Diabetes Mellitus and Latent Tuberculosis Infection: A Systematic Review and Metaanalysis. Clin Infect Dis 2017;64:719-27. [PMID: 27986673 DOI: 10.1093/cid/ciw836] [Cited by in Crossref: 13] [Cited by in F6Publishing: 35] [Article Influence: 2.6] [Reference Citation Analysis]
87 Lin CH, Kuo SC, Hsieh MC, Ho SY, Su IJ, Lin SH, Chi CY, Su SL, Liao CY, Chen YC, Hsu SR, Huang YC, Tseng FC, Wang SY, Dou HY, Lin SD, Lin JS, Tu ST, Yeh YP; Changhua Research Alliance for Tuberculosis Elimination. Effect of diabetes mellitus on risk of latent TB infection in a high TB incidence area: a community-based study in Taiwan. BMJ Open 2019;9:e029948. [PMID: 31662365 DOI: 10.1136/bmjopen-2019-029948] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
88 Zahr RS, Peterson RA, Polgreen LA, Cavanaugh JE, Hornick DB, Winthrop KL, Polgreen PM. Diabetes as an increasingly common comorbidity among patient hospitalizations for tuberculosis in the USA. BMJ Open Diabetes Res Care 2016;4:e000268. [PMID: 27843553 DOI: 10.1136/bmjdrc-2016-000268] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
89 Syal K, Srinivasan A, Banerjee D. VDR, RXR, Coronin-1 and Interferonγ Levels in PBMCs of Type-2 Diabetes Patients: Molecular Link between Diabetes and Tuberculosis. Indian J Clin Biochem 2015;30:323-8. [PMID: 26089620 DOI: 10.1007/s12291-014-0431-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
90 Kornfeld H, West K, Kane K, Kumpatla S, Zacharias RR, Martinez-Balzano C, Li W, Viswanathan V. High Prevalence and Heterogeneity of Diabetes in Patients With TB in South India: A Report from the Effects of Diabetes on Tuberculosis Severity (EDOTS) Study. Chest 2016;149:1501-8. [PMID: 26973015 DOI: 10.1016/j.chest.2016.02.675] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 8.2] [Reference Citation Analysis]
91 Lachmandas E, Vrieling F, Wilson LG, Joosten SA, Netea MG, Ottenhoff TH, van Crevel R. The effect of hyperglycaemia on in vitro cytokine production and macrophage infection with Mycobacterium tuberculosis. PLoS One 2015;10:e0117941. [PMID: 25664765 DOI: 10.1371/journal.pone.0117941] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
92 Séraphin MN, Doggett R, Johnston L, Zabala J, Gerace AM, Lauzardo M. Association between Mycobacterium tuberculosis lineage and site of disease in Florida, 2009-2015. Infect Genet Evol 2017;55:366-71. [PMID: 28993293 DOI: 10.1016/j.meegid.2017.10.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
93 Kumar NP, Banurekha VV, Nair D, Kumaran P, Dolla CK, Babu S. Type 2 diabetes - Tuberculosis co-morbidity is associated with diminished circulating levels of IL-20 subfamily of cytokines. Tuberculosis (Edinb) 2015;95:707-12. [PMID: 26354610 DOI: 10.1016/j.tube.2015.06.004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
94 Ronacher K, van Crevel R, Critchley JA, Bremer AA, Schlesinger LS, Kapur A, Basaraba R, Kornfeld H, Restrepo BI. Defining a Research Agenda to Address the Converging Epidemics of Tuberculosis and Diabetes: Part 2: Underlying Biologic Mechanisms. Chest 2017;152:174-80. [PMID: 28434937 DOI: 10.1016/j.chest.2017.02.032] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 6.4] [Reference Citation Analysis]
95 Bastos HN, Osório NS, Gagneux S, Comas I, Saraiva M. The Troika Host-Pathogen-Extrinsic Factors in Tuberculosis: Modulating Inflammation and Clinical Outcomes. Front Immunol 2017;8:1948. [PMID: 29375571 DOI: 10.3389/fimmu.2017.01948] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
96 Hegazy WAH, Rajab AAH, Abu Lila AS, Abbas HA. Anti-diabetics and antimicrobials: Harmony of mutual interplay. World J Diabetes 2021; 12(11): 1832-1855 [PMID: 34888011 DOI: 10.4239/wjd.v12.i11.1832] [Reference Citation Analysis]
97 Gleeson LE, Sheedy FJ. Metabolic reprogramming & inflammation: Fuelling the host response to pathogens. Semin Immunol 2016;28:450-68. [PMID: 27780657 DOI: 10.1016/j.smim.2016.10.007] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 5.3] [Reference Citation Analysis]
98 Wong KW, Jacobs WR Jr. Postprimary Tuberculosis and Macrophage Necrosis: Is There a Big ConNECtion? mBio 2016;7:e01589-15. [PMID: 26758178 DOI: 10.1128/mBio.01589-15] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
99 Salgado-Bustamante M, Rocha-Viggiano AK, Rivas-Santiago C, Magaña-Aquino M, López JA, López-Hernández Y. Metabolomics applied to the discovery of tuberculosis and diabetes mellitus biomarkers. Biomark Med 2018;12:1001-13. [PMID: 30043640 DOI: 10.2217/bmm-2018-0050] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
100 Huang L, Liu C, Liao G, Yang X, Tang X, Chen J. Vitamin D Receptor Gene FokI Polymorphism Contributes to Increasing the Risk of Tuberculosis: An Update Meta-Analysis. Medicine (Baltimore) 2015;94:e2256. [PMID: 26705207 DOI: 10.1097/MD.0000000000002256] [Cited by in Crossref: 22] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
101 Asare-Baah M, Séraphin MN, Salmon LAT, Lauzardo M. Effect of mixed strain infections on clinical and epidemiological features of tuberculosis in Florida. Infect Genet Evol 2021;87:104659. [PMID: 33276149 DOI: 10.1016/j.meegid.2020.104659] [Reference Citation Analysis]
102 Raposo-García S, Guerra-Laso JM, García-García S, Juan-García J, López-Fidalgo E, Diez-Tascón C, Nebreda-Mayoral T, López-Medrano R, Rivero-Lezcano OM. Immunological response to Mycobacterium tuberculosis infection in blood from type 2 diabetes patients. Immunol Lett 2017;186:41-5. [PMID: 28377108 DOI: 10.1016/j.imlet.2017.03.017] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
103 Kreisel CF, Passannante MR, Lardizabal AA. The Negative Clinical Impact of Diabetes on Tuberculosis: A Cross-Sectional Study in New Jersey. J Endocr Soc 2019;3:62-8. [PMID: 30697601 DOI: 10.1210/js.2018-00203] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
104 Qiu H, Shi Y, Li Y, Shen X, Li R, Yang Q, Pan Q, Yan F. Incident rate and risk factors for tuberculosis among patients with type 2 diabetes: retrospective cohort study in Shanghai, China. Trop Med Int Health 2017;22:830-8. [PMID: 28449358 DOI: 10.1111/tmi.12884] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
105 Yao Y, Zhang H, Liu M, Liu H, Chu T, Tang Y, Zhou Y. Prognostic Factors for Recovery of Patients After Surgery for Thoracic Spinal Tuberculosis. World Neurosurg 2017;105:327-31. [PMID: 28602882 DOI: 10.1016/j.wneu.2017.05.167] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
106 Zhou TJ, Lakshminarayanan S, Sarkar S, Knudsen S, Horsburgh CR, Muthaiah M, Kan CK, Salgame P, Ellner JJ, Roy G, Jenkins HE, Hochberg NS. Predictors of Loss to Follow-Up among Men with Tuberculosis in Puducherry and Tamil Nadu, India. Am J Trop Med Hyg 2020;103:1050-6. [PMID: 32618243 DOI: 10.4269/ajtmh.19-0415] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]